SCHEMBL4986751

SCHEMBL4986751

Nc1ncnc2c1CCN(Cc1c(F)cccc1Cl)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 1/20 0.47
DCPS Q96C86 1/20 0.44
COMT P21964 1/20 0.43
LIMK1 P53667 1/20 0.40
ALDH1A1 P00352 2/20 0.40
ALOX15 P16050 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
PKM P14618 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CACNA1G O43497 4/20 0.39
KCNH2 Q12809 1/20 0.39
GRM2 Q14416 1/20 0.39
TSHR P16473 2/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4988680 0.81 GRM2 (0.44) GRM2
SCHEMBL4990912 0.80 LIMK1 (0.43) LIMK1MEN1KMT2AGRM2
SCHEMBL4988556 0.78 LIMK1 (0.47) LIMK1ALDH1A1MEN1KMT2AKCNH2
SCHEMBL4982960 0.78 LIMK1 (0.61) LIMK1ALDH1A1TDP1MEN1KMT2A
SCHEMBL4993341 0.78 MEN1 (0.51) LIMK1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL4992362 0.77 LIMK1 (0.48) LIMK1ALDH1A1MEN1KMT2AKCNH2
SCHEMBL4991112 0.77 KDM4E (0.47) LIMK1GRM2KDM4ESMN1; SMN2
SCHEMBL4988843 0.77 ALDH1A1 (0.47) LIMK1ALDH1A1MEN1KMT2AKCNH2
SCHEMBL13532613 0.76 CYP2A13 (0.38) CYP2A13DCPSCOMTALDH1A1TDP1
SCHEMBL4985215 0.75 DHFR (0.54) CYP2A13COMTLIMK1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 CYP2A13 1411/4885DCPS 767/4885COMT 3203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.